[Edaily Reporter Lee Hye-ra] #MFC has decided to repurchase 1 billion won worth of its own shares to enhance shareholder value. This decision stems from the assessment that the current stock price is undervalued relative to the company’s potential and intrinsic business value, reflecting management’s commitment to boosting shareholder value.

MFC announced on the 16th that it held a board meeting the previous day and resolved to purchase 1 billion won worth of its own shares on the KOSDAQ market over the next three months, starting today.
The number of shares to be acquired is 350,262 (approximately 4% of the total issued shares), based on the closing price on the day before the board resolution.
MFC is gradually expanding its shareholder-friendly policies, with management taking a direct role. Following CEO Hwang Seong-gwan’s recent on-market purchase using his own funds—which demonstrated his commitment to responsible management to the market—this decision to buy back shares further strengthens the company’s shareholder-centric management approach.
An MFC official stated, “We expect improved profitability and increased corporate value based on the launch of improved new drug ingredients in the second half of the year and the R&D achievements of our AI Formulation Research Center,” adding, “Amid this trend of improved performance, we will strengthen responsible management and continue to pursue policies aimed at enhancing shareholder value.”